Matthew Downs, M.P.H., joined Statistics Collaborative, Inc. (SCI) in 1996. He is a member of the Society for Clinical Trials, for which he has co-authored presentations describing dynamic allocation methods and conditional power.
At SCI, Mr. Downs has managed and analyzed studies of gene therapies against HIV/AIDS infection and studies of treatments of HIV-associated cachexia and Hansen’s disease. He has performed analyses of diagnostic imaging studies and a validation study of a scale measuring the severity of oral mucositis in cancer patients. He has coordinated safety monitoring reports for large, multinational trials in heart disease, sepsis, lung cancer, Parkinson’s disease, and ophthalmology. He has also assisted in the design of a multiple endpoint oncology study and a trial investigating recovery of erectile function following prostatectomy.
A SAS certified professional, he has presented articles at national and regional SAS user group conferences on data visualization and on project management.
He received his B.A. and B.S. from the State University of New York, Geneseo (1994) and his M.P.H. in Epidemiology and Biostatistics from the University of California, Berkeley (1996).